Skip to main content
. 2015 Aug 5;29(9):1269–1285. doi: 10.1210/me.2014-1406

Figure 1.

Figure 1.

Schematic of treatment regimen for WT and Nmp4−/− mice; group 1 mice were subjected to ovx or sham operation at 12 weeks of age and evaluated for bone loss 4-week postop (16 wk of age). Group 2 mice were ovx at 12 weeks of age and began PTH or vehicle therapy at 16 weeks of age for a duration of 4 and 8 weeks. Endpoint analyses included μCT, serum analysis for P1NP and CTXs, and dynamic histomorphometry.